Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
YGYIP Stock Summary
Top 10 Correlated ETFs
YGYIP
In the News
YGYIP Financial details
Company Rating
-
Market Cap
6.56M
Income
-47.21M
Revenue
105.96M
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
415
Optionable
No
Shortable
Yes
Earnings
18 Nov 2019
P/E
-112.58
Forward P/E
-
PEG
-14.47
P/S
0.04
P/B
194.01
P/C
-
P/FCF
-0.34
Quick Ratio
0.22
Current Ratio
1.02
Debt / Equity
2.25
LT Debt / Equity
1.03
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-1.2%
Revenue Q/Q
3.06%
EPS Q/Q
100%
-
-
-
-
SMA20
25%
SMA50
36.36%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-58%
ROE
-196%
ROC
-0.69%
Gross Margin
64%
Oper. Margin
-26%
Profit Margin
-35%
Payout
-
Shs Outstand
32.79M
Shs Float
31.54M
-
-
-
-
Target Price
-
52W Range
0.0101-0.7602
52W High
-
52W Low
-
RSI
90.55
Rel Volume
8.16
Avg Volume
1.02K
Volume
8.31K
Perf Week
42.65%
Perf Month
25%
Perf Quarter
-
Perf Half Y
50.94%
-
-
-
-
Beta
3.064
-
-
Volatility
0.02%, 0.02%
Prev Close
42.65%
Price
0.2
Change
42.65%
YGYIP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2019-12-31
Metric | History | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.01 | 0.01 | 0.01 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 9605.85B | 9619.72B | 481.97B | 528.94B | 636.49B | |
Enterprise value | 9605.87B | 9619.75B | 482.01B | 528.95B | 636.52B | |
P/E ratio | -5.63M | -24.17M | -38.02K | -26.35K | -12.24K | |
Price to sales ratio | 61.34K | 59.14K | 2.91K | 3.26K | 4.32K | |
POCF ratio | 7.03M | -59.75M | -173.81K | -42.82K | -44.4K | |
PFCF ratio | -5.25M | -6.17M | -130.16K | -38.64K | -33.4K | |
P/B Ratio | 508.76K | 506.35K | 64.69K | 23.02K | 21.1K | |
PTB ratio | 508.76K | 506.35K | 64.69K | 23.02K | 21.1K | |
EV to sales | 61.34K | 59.14K | 2.91K | 3.26K | 4.32K | |
Enterprise value over EBITDA | 1.1M | 1.51M | -81.95K | -126.91K | -18.74K | |
EV to operating cash flow | 7.03M | -59.75M | -173.82K | -42.82K | -44.4K | |
EV to free cash flow | -5.25M | -6.17M | -130.17K | -38.64K | -33.41K | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 1.12 | 1.23 | 4.78 | 0.92 | 1.12 | |
Debt to assets | 0.34 | 0.35 | 0.49 | 0.28 | 0.38 | |
Net debt to EBITDA | 1.98 | 3.53 | -5.94 | -4.4 | -0.87 | |
Current ratio | 1.2 | 1.12 | 0.83 | 1.06 | 1.02 | |
Interest coverage | 1.2 | 0.56 | -1.02 | -0.4 | -13.66 | |
Income quality | -0.8 | 0.4 | 0.22 | 0.62 | 0.28 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -1.53 | 0 | 0 | -0.01 | 0 | |
Sales general and administrative to revenue | 0.51 | 0.52 | 0.53 | 0.5 | 0.8 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.32 | 0.32 | 0.38 | 0.29 | 0.25 | |
Capex to operating cash flow | -2.34 | 8.68 | 0.34 | 0.11 | 0.33 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.01 | -0.03 | |
Capex to depreciation | -0.95 | -0.36 | -0.21 | -0.28 | -1.04 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.09 | |
Graham number | 0 | 0 | 0 | 0 | 0.01 | |
ROIC | 0.71 | 0.04 | -0.17 | -0.06 | -0.52 | |
Return on tangible assets | -0.04 | -0.01 | -0.28 | -0.37 | -0.77 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 4.68M | 3.16M | -6.55M | 2.22M | 593K | |
Tangible asset value | -1.16M | -2.24M | -19.78M | 1.28M | 7.61M | |
Net current asset value | -15.68M | -18.54M | -33.77M | -13.98M | -25.39M | |
Invested capital | 1.12 | 1.23 | 4.78 | 0.92 | 1.12 | |
Average receivables | 1.95M | 2.13M | 3.44M | 4.26M | 3.54M | |
Average payables | 6.21M | 7.59M | 9.95M | 10.1M | 8.77M | |
Average inventory | 14.88M | 19.73M | 21.78M | 21.92M | 22.24M | |
Days sales outstanding | 4.19 | 5.52 | 9.74 | 9.22 | 7.38 | |
Days payables outstanding | 40.24 | 46.23 | 61.04 | 45.9 | 61.89 | |
Days of inventory on hand | 103.12 | 121.56 | 114.88 | 117.9 | 154.96 | |
Receivables turnover | 87.14 | 66.12 | 37.49 | 39.6 | 49.43 | |
Payables turnover | 9.07 | 7.89 | 5.98 | 7.95 | 5.9 | |
Inventory turnover | 3.54 | 3 | 3.18 | 3.1 | 2.36 | |
ROE | -0.09 | -0.02 | -1.7 | -0.87 | -1.72 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2020-09-30 for Q3
Metric | History | 2019-09-30 | 2019-12-31 | 2020-03-31 | 2020-06-30 | 2020-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 740.66B | 636.49B | 283.14B | 502.47B | 392.28B | |
Enterprise value | 740.69B | 636.52B | 283.17B | 502.51B | 392.32B | |
P/E ratio | -23.52K | -5K | -12.22K | -27.67K | -19.34K | |
Price to sales ratio | 21.77K | 185.14K | 7.97K | 15.23K | 11.54K | |
POCF ratio | -311.07K | -96.81K | -415.77K | -136.1K | 170.71K | |
PFCF ratio | -172.69K | -104.09K | -160.6K | -110.09K | 532.27K | |
P/B Ratio | 13.19K | 21.1K | 11.58K | 22.56K | 23.33K | |
PTB ratio | 13.19K | 21.1K | 11.58K | 22.56K | 23.33K | |
EV to sales | 21.77K | 185.14K | 7.97K | 15.23K | 11.54K | |
Enterprise value over EBITDA | -112K | -35.11K | -52.6K | -195.38K | -114.48K | |
EV to operating cash flow | -311.08K | -96.81K | -415.82K | -136.11K | 170.72K | |
EV to free cash flow | -172.69K | -104.09K | -160.62K | -110.1K | 532.32K | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.56 | 1.12 | 1.4 | 1.65 | 2.25 | |
Debt to assets | 0.22 | 0.38 | 0.39 | 0.42 | 0.44 | |
Net debt to EBITDA | -3.65 | -1.62 | -5.74 | -13.85 | -10.7 | |
Current ratio | 1.23 | 1.02 | 0.76 | 0.71 | 0.62 | |
Interest coverage | -7.65 | 21.47 | -10.77 | -6.03 | -7.09 | |
Income quality | 0.3 | 0.21 | 0.12 | 0.81 | -0.45 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.01 | -0.07 | -0.08 | -0.07 | |
Sales general and administrative to revenue | 0.7 | 10.76 | 0.65 | 0.64 | 0.63 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.23 | 0.25 | 0.25 | 0.25 | 0.24 | |
Capex to operating cash flow | 0.8 | -0.07 | 1.59 | 0.24 | -0.68 | |
Capex to revenue | -0.06 | 0.13 | -0.03 | -0.03 | -0.05 | |
Capex to depreciation | -1.02 | 1.37 | -0.84 | -0.68 | -1.26 | |
Stock based compensation to revenue | 0.02 | 0.08 | 0.01 | 0.01 | 0.01 | |
Graham number | 0 | 0.01 | 0 | 0 | 0 | |
ROIC | -0.09 | -0.25 | -0.1 | -0.06 | -0.07 | |
Return on tangible assets | -0.07 | -0.47 | -0.09 | -0.07 | -0.08 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 13.45M | 593K | -10.51M | -13.55M | -19.61M | |
Tangible asset value | 23.41M | 7.61M | 2.51M | 950K | -3.9M | |
Net current asset value | -12.74M | -25.39M | -30.4M | -32.08M | -36.91M | |
Invested capital | 0.56 | 1.12 | 1.4 | 1.65 | 2.25 | |
Average receivables | 39.08M | 19.48M | 3M | 2.78M | 2.83M | |
Average payables | 34.08M | 21.59M | 10.01M | 10.1M | 9.32M | |
Average inventory | 23.95M | 22.91M | 22.72M | 22.86M | 22.51M | |
Days sales outstanding | 95.16 | 78.09 | 7.65 | 6.91 | 8.27 | |
Days payables outstanding | 214.98 | -45.31 | 62.62 | 64.22 | 59.41 | |
Days of inventory on hand | 145.66 | -113.45 | 130.01 | 159.77 | 139.19 | |
Receivables turnover | 0.95 | 1.15 | 11.76 | 13.02 | 10.88 | |
Payables turnover | 0.42 | -1.99 | 1.44 | 1.4 | 1.51 | |
Inventory turnover | 0.62 | -0.79 | 0.69 | 0.56 | 0.65 | |
ROE | -0.14 | -1.05 | -0.24 | -0.2 | -0.3 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
YGYIP Frequently Asked Questions
What is Youngevity International, Inc. stock symbol ?
Youngevity International, Inc. is a US stock , located in Chula vista of Ca and trading under the symbol YGYIP
What is Youngevity International, Inc. stock quote today ?
Youngevity International, Inc. stock price is $0.2 today.
Is Youngevity International, Inc. stock public?
Yes, Youngevity International, Inc. is a publicly traded company.